GLP-1 Class Research Overview (Educational)
Non-promotional context on incretin tools used in metabolic and endocrine laboratories.
This overview links published science to catalog SKUs — not patient treatment pathways.
Reference tools in metabolic research
- Semaglutide — GLP-1 receptor–biased reference for comparator arms
- Tirzepatide — dual GIP/GLP-1 agonist for pathway coverage studies
- Retatrutide — triple agonist (GLP-1 + GIP + glucagon) for energy-expenditure endpoints
Suggested reading (external)
- ClinicalTrials.gov — trial registry
- Peer-reviewed journals — NEJM, Lancet, and society publications on incretin outcomes
Catalog
Browse metabolic research peptides with COA on request.